Earnings Per Share, Basic in USD/shares of Theravance Biopharma, Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Theravance Biopharma, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to Q3 2025.
  • Theravance Biopharma, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was 0.07 USD/shares.
  • Theravance Biopharma, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares.
  • Theravance Biopharma, Inc. annual Earnings Per Share, Basic for 2024 was -1.15 USD/shares, a 15% decline from 2023.
  • Theravance Biopharma, Inc. annual Earnings Per Share, Basic for 2023 was -1 USD/shares, a 108% decline from 2022.
  • Theravance Biopharma, Inc. annual Earnings Per Share, Basic for 2022 was 11.9 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Theravance Biopharma, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0.07 +$0.33 Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $0 $1.09 +$1.43 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 -$1 $0 $0 -12.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 -$1 $0 $0 -82.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-07
Q3 2024 -$1 $0 $0 -52.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $0 $0 $0 -21.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $0 $0 +$0.11 +31.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $0 $0 $0 -13.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-07
Q3 2023 $0 $0 -$12 -101% Jul 1, 2023 Sep 30, 2023 10-K 2025-03-07
Q2 2023 $11.00 $0 $0 -155% Apr 1, 2023 Jun 30, 2023 10-K 2025-03-07
Q1 2023 $11.00 $0 $0 -2.94% Jan 1, 2023 Mar 31, 2023 10-K 2025-03-07
Q4 2022 $11.00 $0 +$0.28 +65.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $11.00 $12.10 +$12.60 Jul 1, 2022 Sep 30, 2022 10-K 2024-03-01
Q2 2022 -$1 $0 +$0.69 +86.3% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-01
Q1 2022 -$2 $0 +$0.90 +72.6% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-01
Q4 2021 -$2 $0 +$0.49 +53.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$3 $0 +$0.68 +58.6% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-01
Q2 2021 -$4 -$1 +$0.20 +20% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 -$4 -$1 +$0.16 +11.4% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q4 2020 -$4 -$1 Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$1 Jul 1, 2020 Sep 30, 2020 10-K 2022-02-28
Q2 2020 -$1 Apr 1, 2020 Jun 30, 2020 10-K 2022-02-28
Q1 2020 -$1 Jan 1, 2020 Mar 31, 2020 10-K 2022-02-28

Theravance Biopharma, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 $0 -15% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 -$1 -$13 -108% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 $11.90 +$14.70 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$3 +$1.59 +35.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 -$4 $0 -4.94% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$4 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.